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MaThis review summarizes the detrimental effects of cigarette and noncigarette emission exposure on autonomic
function, with particular emphasis on the mechanisms of acute and chronic modulation of the sympathetic nervous
system. We propose that the nicotine and ﬁne particulate matter in tobacco smoke lead to increased sympathetic nerve
activity, which becomes persistent via a positive feedback loop between sympathetic nerve activity and reactive oxidative
species. Furthermore, we propose that baroreﬂex suppression of sympathetic activation is attenuated in habitual
smokers; that is, the baroreﬂex plays a permissive role, allowing sympathoexcitation to occur without restraint in the
setting of increased pressor response. This model is also applicable to other nontobacco cigarette emission exposures
(e.g., marijuana, waterpipes [hookahs], electronic cigarettes, and even air pollution). Fortunately, emerging data
suggest that baroreﬂex sensitivity and autonomic function may be restored after smoking cessation, providing further
evidence in support of the health beneﬁts of smoking cessation. (J Am Coll Cardiol 2014;64:1740–50) © 2014 by the
American College of Cardiology Foundation. Open access under CC BY-NC-ND license.E xposure to cigarette smoke is the number onepreventable cause of cardiovascular disease inthe United States (1). Although smoking rates
in the United States have declined over the past 5 de-
cades, 43.8 million Americans (19% of the adult pop-
ulation) continue to smoke, and smoking accounts
for 440,000 deaths in the United States per year (2).
This persistence of cigarette smoking, coupled with
the recent diversiﬁcation of available inhaled sub-
stances and delivery systems, including marijuana,
electronic cigarettes (e-cigarettes), and waterpipes
(hookahs), and the recent recognition that exposure
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Although many of the potential mechanisms by
which smoking dramatically increases cardiac risk
and mortality, including adverse effects on platelets
and endothelium, and increased inﬂammation and
oxidative stress were recently comprehensively re-
viewed (3), the effects of tobacco exposure on the
autonomic nervous system were not. The autonomic
nervous system is composed of afferent nerve ﬁbers
located throughout the body, including the lungs,
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AB BR EV I A T I O N S
AND ACRONYM S
CB = cannabinoid
e-cigarette = electronic
cigarette
HRV = heart rate variability
PM2.5 = ﬁne particulate
matter <2.5 mm in
hydrodynamic diameter
SNA = sympathetic
nerve activity
TRPA1 = transient receptor
potential ankyrin 1
TRPV1 = transient receptor
potential vanilloid 1
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1741(chemical) stimuli, with the general purpose of
defending homeostasis. When stimulated, these
afferent ﬁbers relay impulses back to the central
nervous system, where they may have either excit-
atory or inhibitory inﬂuences. For example, to pre-
vent wide ﬂuctuations in blood pressure, arterial
baroreceptors, afferent nerves located in the aortic
arch and carotid sinus, are sensitive to mechanical
stimuli; when an increase in blood pressure results in
stretch and distortion, they send inhibitory signals
back to the brain that decrease central sympathetic
efferent nerve outﬂow and increase vagal outﬂow.
Strong evidence supports the concept that smoking
alters the balance of the autonomic nervous system,
and speciﬁcally, that tobacco smoke exposure leads
to a predominance of sympathetic nerve activity
(SNA). Cigarette smoking increases the risk for atrial
and ventricular arrhythmias (4,5), sudden death (1),
and acute myocardial infarction and causes hemo-
dynamic changes that exacerbate heart failure (6),
and increased SNA contributes to all of these com-
plications (Table 1).
We will review the evidence that: 1) nicotine, with
a contribution from ﬁne particulate matter (PM2.5;
deﬁned as <2.5 mm in hydrodynamic diameter), un-
derlies the acute sympathoexcitatory effects of to-
bacco smoke, which are opposed by intact arterial
baroreﬂexes; 2) PM2.5 in tobacco smoke generates
reactive oxygen species and inﬂammation, which
play a crucial role in sustained sympathetic activa-
tion; baroreﬂexes are blunted in habitual smokers,
and, therefore, play a permissive role; and 3) this
proposed model, integrating a positive feedback loop
between SNA and reactive oxygen species/inﬂam-
mation, and a blunted negative feedback loop be-
tween SNA and the baroreﬂex, is potentially shared
by other toxic emission sources, including marijuana,
e-cigarettes, waterpipes, and air pollution. Details of
the PubMed search and additional references and
discussion are available in the Online Appendix.
EVIDENCE THAT ACUTE AND
LONG-TERM TOBACCO SMOKE
EXPOSURE INCREASES SNA
ACUTE EXPOSURE. Tobacco smoke is composed of
gases and PM2.5, consisting of over 4,000 identiﬁed
potential toxicants, including nicotine. Because
nicotinic acetylcholine receptors are present in the
central nervous system, autonomic ganglia, and at
the neuromuscular junction, early investigations of
the neurovascular effects of tobacco focused on the
acute effects of nicotine, which play an important
role in its interactions with the autonomic nervoussystem. Acutely, nicotine causes the local
release of catecholamines from adrenergic
nerve terminals (7,8). In humans, nicotine
exposure through smoking or intravenous
nicotine administration leads to an acute in-
crease in blood pressure and heart rate,
peaking within 5 to 10 min of exposure (9,10).
Although plasma nicotine levels continue to
rise with increased exposure, nicotine toler-
ance develops rapidly, and the hemodynamic
effects stabilize or decline (9,11). Direct
microneurographic recordings of post-
ganglionic muscle SNA in humans during
nicotine administration have shown that,
in addition to releasing catecholamines at
the adrenergic nerve terminal, nicotine increases
SNA (12).
Heart rate variability (HRV), used as a measure of
the relative, typically reciprocal, inﬂuence of sym-
pathetic and vagal input to the heart, can be quanti-
ﬁed using either time domain or frequency domain
analyses, which provide comparable results. De-
pressed HRV ﬁrst emerged as a powerful independent
predictor of increased mortality following myocardial
infarction (13) and signiﬁes a shift in the sym-
pathovagal balance toward sympathetic predomi-
nance, accompanied by decreased vagal activity.
Acute oral nicotine exposure in never-smokers
acutely decreases HRV, consistent with a shift in the
cardiac sympathovagal balance toward increased SNA
(14). The observations that during cigarette smoking
(but not during sham smoking), plasma catechol-
amines, blood pressure, and heart rate increase
acutely, and that acute hemodynamic effects are
prevented by pharmacological adrenergic blockade
support the notion that the acute cardiovascular
effects of cigarette smoke are also mediated by the
effects of nicotine on the autonomic nervous
system (7).
The net effect of acute smoking and nicotine
exposure on SNA depends on the relative balance be-
tween the direct sympathetic excitatory effects of to-
bacco smoke and the opposing sympathoinhibitory
effects mediated by the baroreﬂex (Figure 1). Para-
doxically, early studies reported a sympathoinhibitory
effect of acute tobacco smoke exposure in humans
(15–18). Follow-up studies revealed that this apparent
decrease in muscle SNA was mediated by the en-
gagement of the baroreﬂex in response to the acute
increase in blood pressure; if the increase in blood
pressure was prevented pharmacologically, acute
tobacco exposure increased muscle SNA (17,18). In
older long-term smokers with relatively impaired
baroreﬂex function, acute smoking produces an
TABLE 1 Adverse Cardiovascular Sequelae of
Sympathetic Predominance
[ Arrhythmias [ Heart Failure
[Myocardial
Infarction
Y Refractory period Y ECC [ Vasoconstriction
[ Triggered activity [ Apoptosis [ Vasospasm
[ Automaticity [ Oxidative stress [ Shear stress
Y VF threshold [ Afterload [ Platelet aggregation
[ Ischemia [ MVO2 ([ HR [ BP [
Contractility)
BP ¼ blood pressure; ECC ¼ excitation-contraction coupling; HR ¼ heart rate;
MVO2 ¼ myocardial oxygen consumption; VF ¼ ventricular ﬁbrillation.
Middlekauff et al. J A C C V O L . 6 4 , N O . 1 6 , 2 0 1 4
Smoking and the Autonomic Nervous System O C T O B E R 2 1 , 2 0 1 4 : 1 7 4 0 – 5 0
1742increase in muscle SNA due to a lack of baroreﬂex
restraint. In contrast, in younger, healthy smokers
whose negative baroreﬂex feedback loop is intact,
acute smoking leads to a decrease in muscle SNA due
to the activation of intact baroreﬂexes by the pressor
effect of catecholamines released from nerve termi-
nals by cigarette smoke. A signiﬁcant correlation
between baroreﬂex sensitivity and changes in
muscle SNA during acute smoke exposure has
been reported (19,20). Interestingly, in middle-ageTobacco Smoke
SNS Activity
BP
SNA
SNA
Impaired
BRS
Intact
BRS
BRS
FIGURE 1 Acute Effects of Tobacco Smoke Exposure on SNA
The acute effects of tobacco smoke on sympathetic nerve
activity (SNA) depend on the net balance of the sympathetic
excitatory effect of cigarette smoke on central neural outﬂow,
and the sympathetic inhibitory effect of the baroreﬂex, activated
by the increase in blood pressure from smoking. When the bar-
oreﬂex is intact, SNA is suppressed, but when the baroreﬂex is
chronically impaired, as it is in many vulnerable populations, SNA
increases. BP ¼ blood pressure; BRS ¼ baroreﬂex sensitivity;
SNS ¼ sympathetic nervous system.habitual smokers, acute smoking increases blood
pressure to a greater extent in women compared with
men (21). One would then expect this augmented
blood pressure response to reﬂexively suppress SNA
to a greater degree in women, but SNA responses to
acute smoking are similar in both sexes, consistent
with an augmented sympathetic response to tobacco
smoke exposure in women (21). It is tempting to
speculate that habitual smoking leads to greater
baroreﬂex impairment in women than in men.
Indeed, smoking has been reported to confer a
greater cardiovascular risk in female smokers than
in male smokers (22). In addition to older patients,
patients with hypertension, heart failure, or diabetes
also have impaired baroreﬂex function, perhaps
illuminating one potential mechanism whereby
smoking may increase cardiac risk in these vulner-
able groups.
Similar to direct tobacco smoke exposure, second-
hand smoke exposure also leads to sympathoex-
citation. Secondhand smoke is composed of w15%
exhaled mainstream smoke and w85% side-stream
unﬁltered smoke emerging from the tip of a burning
cigarette, which contains even greater amounts of
toxic compounds than does mainstream smoke (23).
The acute effects of secondhand smoke on the auto-
nomic nervous system in never-smokers have been
evaluated using microneurography and HRV, and
both techniques conﬁrmed increased SNA during
secondhand smoke exposure (24,25).
Nicotine is not the only component of cigarette
smoke that mediates an increase in SNA; in short-
term studies, PM2.5 also increased sympathetic tone
(26). Studies of the effects of air pollution on auto-
nomic function helped to elucidate the role of PM2.5
versus nicotine on SNA. Air pollution generated
by the combustion of organic materials (speciﬁcally
fossil fuels) is comparable in particle size and con-
stituents to tobacco smoke, which is similarly gener-
ated by the combustion of organic materials (tobacco
leaves), but with two major differences (27,28). First,
the daily dose (in mg) of inhaled particulates from
air pollution is generally several orders of magnitude
less than is that of smoking a pack of cigarettes a day
and is on par with that of a nonsmoker exposed to
secondhand smoke when living with a smoker (27).
It is important to remember that cardiovascular risk
stemming from exposure to PM2.5 has a steep dose–
response curve, so that even low levels of PM2.5
exposure are potentially dangerous (27). Second, air
pollution does not contain nicotine. This latter dif-
ference permits inferences regarding the effects of
PM2.5 on the autonomic nervous system, independent
of those of nicotine. As will be detailed later, acute
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FIGURE 2 Elevated SNA During the Ovarian Cycle in Smokers
Sympathetic neurograms using microneurography of the original nerve recordings from
two representative smokers (Sm) and two never-smokers (NS) during both the early
follicular (EF) and midluteal (ML) phases of the ovarian cycle (A). In the never-smokers,
sympathetic nerve activity (SNA) is higher in the ML phase and decreases in the EF phase,
but in smokers, SNA remains elevated during the EF phase. Muscle SNA (MSNA) during the
ML and EF phases of the ovarian cycle in smokers and never-smoker controls (B).
*Signiﬁcant within-group difference for ML versus EF in controls. **Signiﬁcant between-
group difference during the EF phase. The overall analysis of variance F-test indicated a
signiﬁcant difference in the ovarian pattern of SNA between the two groups.
HB ¼ heartbeats. Adapted with permission from Park and Middlekauff (31).
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1743exposure to air pollution increases SNA in both ani-
mal models and in humans and is associated with
increased cardiovascular risk (28,29), suggesting an
important role for PM2.5.
In summary, acute cigarette smoke exposure in
humans is associated with acute increases in blood
pressure and heart rate, which have potentially detri-
mental effects in patients with heart failure, coronary
artery disease, and arrhythmias (4,6). These acute
hemodynamic effects are mediated by both increased
catecholamine release and increased efferent SNA.
Because nicotine administration mimics the hemody-
namic and neurovascular changes induced by acute
cigarette smoke exposure, a major role for nicotine
in mediating these acute sympathoexcitatory effects
is assumed and likely. Extrapolating from the effects
of gases and PM2.5 in air pollution, which consists of
similar toxicants to tobacco smoke, but without the
nicotine, the gases and PM2.5 present in tobacco
smoke also contribute to the acute shift in the auto-
nomic balance toward sympathetic predominance.
LONG-TERM EXPOSURE. Although nicotine may be
an important mediator of acute responses during to-
bacco smoke exposure, tachyphylaxis to nicotine and
its neural effects is rapidly acquired (8). However, the
neurovascular effects of PM2.5 in tobacco smoke may
become sustained and chronic (30). Numerous re-
ports have used HRV to assess chronic cardiac
sympathovagal balance, and most have conﬁrmed
decreased HRV; that is, a shift toward increased
sympathetic dominance in habitual smokers com-
pared with nonsmokers and former smokers (24).
Interestingly, smoking cessation as brief as 7 days has
been associated with increased HRV, consistent with
a shift toward the restoration of normal sym-
pathovagal balance (24,25). Nonsmokers exposed
long-term to secondhand smoke also have decreased
HRV compared with that in nonsmokers without
concurrent secondhand exposure (24,25). Smokers
continued to smoke during data acquisition in all of
these studies of the long-term effects of tobacco
smoke exposure on SNA described in the preceding
text; thus, it is not possible to determine on the basis
of these studies whether the autonomic nervous
system effects are all attributable to acute, intermit-
tent nicotine exposure or to long-term modulation of
autonomic function.
To determine whether SNA is elevated in smokers
in the absence of acute smoke exposure, we directly
measured resting SNA in young women who were
habitual smokers but who had abstained from smok-
ing for 12 h or w6 nicotine half-lives, and in those
who had never smoked. Because in women not taking
oral contraceptive pills, muscle SNA varies during themenstrual cycle, peaking during the high-hormone
mid-luteal phase, and declining during the early
follicular phase, we examined the inﬂuence of the
ovarian cycle on muscle SNA in these groups (31). We
conﬁrmed this ﬂuctuation in muscle SNA with the
ovarian cycle in never-smokers, but found that it
was abolished in women who smoked. Muscle SNA
remained elevated during the early follicular phase
in smokers, consistent with a greater sympathetic
burden in premenopausal women who smoked
(Figure 2). We recently extended these studies to
former smokers and to women exposed to second-
hand smoke (32). Interestingly, we found the same
increased sympathetic burden in women exposed
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1744to secondhand smoke as in habitual smokers. How-
ever, in former smokers, the SNA pattern was indis-
tinguishable from the pattern seen in never-smokers,
consistent with the notion that these effects of to-
bacco smoke are reversible. Hering et al. (33) used
microneurography to directly compare resting sym-
pathetic levels in the absence of acute nicotine ex-
posure in hypertensive patients who were habitual
smokers and in nonsmokers. Sympathetic levels were
signiﬁcantly greater in smokers, consistent with a
chronic sympathoexcitatory effect attributable to
habitual smoking (33). In summary, these ﬁndings
are consistent with a sustained, chronic increase in
SNA in habitual smokers, beyond the effects attrib-
utable to acute nicotine exposure. Furthermore, this
pattern of increased SNA returns to normal with
smoking cessation.
Potential mechanisms underlying this chronic
increased sympathetic burden with smoking are
depicted in the Central Illustration, and include: 1)
activation of lung afferent C-ﬁbers, which have anCENTRAL ILLUSTRATION Proposed Model by Which Tobacco Smo
Fine particulate matter <2.5 mm in hydrodynamic diameter (PM2.5) in
through generation of oxidative stress, which then initiates neurogen
reﬂexively increase systemic (speciﬁcally cardiac) sympathetic nerve a
further increasing cardiac SNA in a positive feedback loop. Nicotine in
ventrolateral medulla, and decreases nitric oxide production centrally
pression of sympathetic activation is attenuated in habitual smokers by
may induce neuroplasticity in the nucleus tractus solitarius, the ﬁrst
baroreﬂex responsiveness in smokers [34,35]); 2) oxidative stress (cig
to generate oxidative stress [3]; in animal models, free radicals atten
baroreceptor activity [36,37]); and 3) endothelial dysfunction (chronic
vascular stiffness; vascular reactivity mediated by nitric oxide is impa
baroreceptors through changes in stretch of the vascular wall are dam
sympathetic nervous system.excitatory inﬂuence on central sympathetic outﬂow,
by PM2.5, either directly or through the generation
of reactive oxygen species; 2) direct nicotine inter-
action with nicotinic receptors, as well as a
more enduring nicotine effect of nitric oxide
depletion in the central nervous system, both
excitatory; 3) persistent attenuation of the inhibi-
tory baroreﬂex, so that it plays a permissive role;
and 4) activation of peripheral arterial chemore-
ceptors, also excitatory. The remainder of this re-
view will focus on roles of lung afferent C-ﬁbers
and the baroreﬂexes, including their interactions
with oxidative stress/inﬂammation in mediating this
sympathetic predominance in habitual smokers.
Multiple studies have shown that smoking increases
inﬂammation and oxidative stress both acutely and
chronically (3). The increase in oxidative stress in
the lungs leads to increased sympathetic activation
via activation of lung afferent neurons. Chronic
sympathetic activation leads, in turn, to further
vascular oxidative stress, leading to a vicious cycleke Exposure May Increase Central Sympathetic Outﬂow
tobacco smoke stimulates lung afferent C-ﬁbers, either directly or
ic inﬂammation, further stimulating lung afferents. Lung afferents
ctivity (SNA), which then increases cardiac inﬂammatory oxidation,
tobacco smoke stimulates nicotinic receptors in the rostral
, thereby increasing central sympathetic outﬂow. Baroreﬂex sup-
3 potential mechanisms: 1) neuroplasticity (PM2.5 in tobacco smoke
synapse of the baroreceptor afferents, thereby directly altering
arette smoke, through particulate matter and/or nicotine, is known
uated baroreceptor activity, while oxyradical scavengers increased
active and passive tobacco exposure is associated with increased
ired [38,39]; thus, blood pressure ﬂuctuations transmitted to the
pened). NO ¼ nitric oxide; ROS ¼ reactive oxygen species; SNS ¼
CNS
L-Arg       nNOS NO
RVLM
Nicotine
Receptors
SNA
SNA
Nicotine
FIGURE 3 Direct and Indirect (via nNOS) Sympathomimetic
Effects of Nicotine From Tobacco Smoke Exposure
There are at least two plausible mechanisms by which cigarette
smoke may directly interact with the central nervous system and
increase central sympathetic outﬂow: 1) stimulation of excitatory
nicotinic receptors; and/or 2) inhibition of the inhibitory neuro-
transmitter nitric oxide. CNS ¼ central nervous system; L-Arg ¼
L-arginine; nNOS ¼ neuronal nitric oxide synthase; NO ¼ nitric
oxide; RVLM ¼ rostral ventrolateral medulla; SNA ¼ sympathetic
nerve activity.
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1745that results in sustained sympathoexcitation. This
model also has important implications for other
emissions, including marijuana, e-cigarettes, hoo-
kahs, and air pollution.
MECHANISMS OF SYMPATHETIC ACTIVATION
WITH TOBACCO SMOKE EXPOSURE
STIMULATION OF LUNG AFFERENT C-FIBERS. Air-
ways are lined with vagal afferent nerve ﬁbers,
including nonmyelinated afferent C-ﬁbers sensitive
to noxious chemicals (29). A subset of these vagal
C-ﬁbers express the acid-sensitive transient receptor
potential (TRP) channels, which, when exposed to
irritants, release neuropeptides locally, resulting in
a local inﬂammatory response. This inﬂammatory
response is characterized by the cough reﬂex, mucous
secretion, and bronchoconstriction and thereby
defends against inspired toxicants (29,40). This
neurogenic inﬂammation creates a more sustained
inﬂammatory oxidative environment, which further
stimulates lung afferent ﬁbers, thus reﬂexively in-
creasing efferent SNA (40–43). In addition to neuro-
genic inﬂammation, toxicants in cigarette smoke
and diesel exhaust may also directly stimulate acid-
sensitive TRP vanilloid 1 (TRPV1) or ankyrin 1
(TRPA1) receptors on lung afferent C-ﬁbers, thereby
directly stimulating the lung afferents, which, in
turn, are integrated centrally and reﬂexively increase
efferent SNA, including cardiac SNA (29,40–50). The
resultant increase in efferent cardiac SNA generates
further inﬂammation and oxidative stress in the heart
in a positive feedback loop (29,42). The reﬂex in-
crease in SNA mediated by PM2.5 activation of TRPV1
receptors also increases cardiac vulnerability to ar-
rhythmias in this animal model (47) (Central
Illustration).
In summary, in animal studies of inhaled toxicants
in tobacco smoke and diesel exhaust, PM2.5 generates
lung oxidative stress and stimulates TRPV1 and
TRPA1 receptors present on lung afferent C-ﬁbers,
leading to reﬂexively increased efferent cardiac SNA.
Increased cardiac SNA causes further generation of
cardiac oxidative stress, as well as increased suscep-
tibility to arrhythmias. Whether this reﬂex sequence
occurs in humans is unknown and mandates further
study.
DIRECT AND INDIRECT (VIA NITRIC OXIDE
SYNTHASE) NICOTINE EFFECTS. Studies to explain
the chronic changes in SNA mediated by a central
neural action of tobacco smoke have focused on two
potential mechanisms (Figure 3): 1) a direct effect of
nicotine on receptors in the central nervous system,and 2) nicotine-mediated inhibition of neuronal nitric
oxide synthase, which decreases central nitric oxide
availability, thereby removing its tonic inhibitory
effect on central sympathetic outﬂow. The relative
importance of these mechanisms in humans remains
uncertain.
ATTENUATED BAROREFLEX SENSITIVITY AND
DISRUPTION OF NEGATIVE FEEDBACK LOOP. Blunted
baroreﬂex sensitivity can lead to chronic sympa-
thetic nervous system activation at baseline, and
exaggerated increases in SNA acutely during smok-
ing if the activation of baroreceptors fails to appro-
priately suppress central sympathetic neural output.
In most studies of the baroreﬂex in smokers, they
abstained from smoking for several hours, during
which time nicotine levels and tolerance subsided.
Acute smoking was then reintroduced as the blood
pressure stimulant to test the baroreﬂex, potentially
confounding any chronic impairment of the barore-
ﬂex with the effects of acute smoke exposure. With
150
100
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EF ML ML ML MLEF EFEF
Never Current Former Passive
Smoking Group
* * * p<0.05
TA
/m
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FIGURE 4 Comparison of Baroreﬂex Control of SNA in Premenopausal Women,
by Menstrual Phase
BRS (total SNA [TA]/min/mm Hg) was signiﬁcantly blunted during both the EF and ML
phases in current smokers compared with never-smokers. Baroreﬂex sensitivity was not
signiﬁcantly different between menstrual phases within any group. Adapted with
permission from Middlekauff et al. (32). Abbreviations as in Figures 1 and 2.
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consistently blunted in smokers compared with
otherwise-matched nonsmokers (51–54). Nonethe-
less, it remains difﬁcult to distinguish acute hemo-
dynamic and neural effects mediated by nicotine
from those potentially mediated by a chronic im-
pairment of the baroreﬂex.
We reported the ﬁrst direct recordings of muscle
SNA during pharmacological baroreﬂex testing in
active smokers who had abstained from smoking
for $12 h compared with never-smokers to deter-
mine whether baroreﬂex control of muscle SNA is
chronically impaired in habitual smokers (32). We
found that in women who were habitual smokers,
baroreﬂex control of muscle SNA was signiﬁcantly
blunted compared with that in never-smokers
(Figure 4). Interestingly, we found that in women
who had stopped smoking >1 year, baroreﬂex con-
trol of muscle SNA was no different from that of
never-smokers, consistent with the reversibility of
this adverse smoking effect. Whether baroreﬂex
control of muscle SNA in men who smoke is also
impaired is unknown and is an active area of
research in our laboratory. Attenuation of the bar-
oreﬂex inhibition in smokers may stem from one or
more plausible mechanisms: 1) oxidative stress;
2) endothelial dysfunction; and/or 3) neuroplasticity
(Central Illustration).In summary, sustained attenuation in baroreﬂex
inhibition of central sympathetic outﬂow, mediated
by PM2.5, and possibly nicotine, likely plays a
permissive role, allowing for increased sympathetic
outﬂow in habitual smokers.
AUGMENTED ARTERIAL CHEMOREFLEX SENSITIVITY.
Acute activation of peripheral arterial chemorecep-
tors, located on carotid and aortic bodies, leads to
acute increases in SNA, as well as rate and volume of
breathing; chronic arterial chemoreﬂex sensitization
in smokers could lead to sustained sympathetic
activation. Arterial chemoreceptors are activated by
hypoxia, to which habitual smokers are susceptible
due to underlying lung damage and exposure to
carbon monoxide in tobacco smoke. However,
to date, there is no evidence for augmented arterial
chemoreceptor sensitivity in habitual smokers
(31,55).
NONTOBACCO CIGARETTE SMOKE EMISSIONS. For
the emissions of each nontobacco cigarette product
(Table 2), we will address two questions: 1) What is
the evidence that the emission increases cardiovas-
cular risk?; and 2) Given the proposed model, does the
emission have known or potential effects on the
autonomic nervous system?
Mar i juana . Marijuana is the most widely used illicit
drug in the United States, and its use is increasing
(56); several states have legalized its use for medical
and/or recreational purposes, contributing to the
misperception that it is safe. Large epidemiological
studies reporting the cardiac risk associated with
marijuana are lacking, but case reports and cohort
studies have reported that smoking marijuana is
associated with an increased risk for triggering an
acute myocardial infarction (57).
Marijuana may be expected to have signiﬁcant
interactions with the autonomic nervous system
because marijuana smoke is generated from the
combustion of organic materials and thus contains
many of the same gases and PM2.5 emissions, but in
even greater concentrations than those found in
tobacco smoke (58). The proinﬂammatory and sym-
pathoexcitatory effects of these PM2.5 emissions may
be modulated, however, by the presence of delta-
9-tetrahydrocannabinol, the main active ingredient
in marijuana that binds to cannabinoid (CB) receptors
1 and 2. CB1 and CB2 receptors are found through-
out the autonomic nervous system, including on
sympathetic afferents. The activation of presyn-
aptic CB1 receptors localized to sympathetic efferent
neurons inhibits catecholamine release (59,60) and
thus opposes the deleterious, sympathoexcitatory
effects of particulates. Furthermore, CB1 and TRPV1
TABLE 2 Hemodynamic and Autonomic Effects of Noncigarette Emissions Exposure
Exposure Key Constituents
Hemodynamic
Characteristics ANS Cardiac Risk
Marijuana (inhaled) PM, D9-THC gases (e.g., CO) [ BP, [ HR, orthostatic
hypotension
[ HRV [ MI risk
E-cigarettes PM, nicotine Unknown Unknown Unknown
Waterpipe (hookah) PM, nicotine, gases (e.g., CO) [ BP, [ HR Y BRS, Y HRV Unknown, but likely similar
to cigarette smoke
Air Pollution PM, gases (e.g., CO) Unknown Y HRV [ CV risk short-/long-term
ANS ¼ autonomic nervous system; BRS ¼ baroreﬂex sensitivity; CO ¼ carbon monoxide; CV ¼ cardiovascular; E ¼ electronic; HRV ¼ heart rate variability; MI ¼ myocardial
infarction; PM ¼ particulate matter; D9-THC ¼ delta-9-tetrahydrocannabinoid.
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opposing effects on neural function (61,62). CB1
activation by delta-9-tetrahydrocannabinol inhibits
neurotransmission and neurogenic inﬂammation
(59,60). In the only published report of the effects of
marijuana on the autonomic nervous system, HRVwas
compared between 72 chronic marijuana users and 72
nonusers, and somewhat surprisingly, an increase
in HRV was reported, consistent with an increase
in vagal over sympathetic tone (62). Conﬁrmatory
studies are warranted.
In summary, case reports and cohort studies suggest
that smoking marijuana carries an increased risk
for triggering an acute infarct. Sympathoexcitatory
effects of PM2.5 may be countered by delta-
9-tetrahydrocannabinol interactions with CB1 re-
ceptors on efferent nerve terminals, and CB1
co-expression with TRPV1 receptors on vagal
C-afferents. Considering the widespread and in-
creasing use of marijuana, physiological studies of its
acute and chronic autonomic effects and long-term
cardiovascular sequelae in humans are needed.
Elect ron ic (e ) -c igarettes . Relatively recently, a
new source of emissions, the e-cigarette, was intro-
duced and is gaining unprecedented popularity,
especially among young people. Although e-ciga-
rettes are not cigarettes at all (no tobacco, no smoke),
they are similar to tobacco cigarettes as a source
of gases, PM2.5, and nicotine. Whether they too acti-
vate the sympathetic nervous system and generate
increased oxidative stress and inﬂammation, leading
to an increased risk for cardiovascular disease,
remain unknown. Because they are relatively new,
and perhaps unfamiliar, a little background is war-
ranted. An e-cigarette is a nicotine-dispensing device
in which a mixture of chemicals (“e-liquid”) in a
chamber is intermittently heated and aerosolized
when a battery-powered heating unit is triggered by
an inhalation (“puff”). There is almost a complete
overlap in PM2.5 size and concentration between
tobacco smoke and e-cigarette vapor, but tobaccosmoke differs fundamentally from e-vapor in that
only tobacco smoke is produced by the combustion of
organic material, and it is the combusted organic
PM2.5 that confers the greatest toxicity (28). In the few
available reports, mainstream e-vapor is void of car-
bon monoxide and other toxic gases and has trace to
no detectable toxicants, including volatile organic
compounds, carbonyls, tobacco speciﬁc nitrosamines,
polycyclic aromatic hydrocarbons, and metals (63);
the concentrations of these toxicants, if detected, are
9 to 450 times lower in e-vapor than in mainstream
smoke from tobacco cigarettes (63).
E-liquid usually contains nicotine, although this
is not obligatory, as well as an excipient, for
example, propylene glycol (antifreeze) and/or glyc-
erin, and ﬂavors. Nicotine exposure in mainstream
or secondhand e-vapor depends on the nicotine
content in the e-liquid, but the nicotine concentra-
tion in even the most nicotine-concentrated e-liquid
is less than that in tobacco cigarettes measured at 5
and 20 min of ad lib use (64). The principle
component of e-liquid and e-vapor is propylene
glycol, classiﬁed as “generally recognized as safe” by
the U.S. Food and Drug Administration (FDA) and
present in many common, FDA-approved injectable
medications.
Unfortunately, at present, there are no animal or
human data on the health effects of e-cigarettes, and
extrapolation for other forms of nicotine replacement
therapy is hazardous, because oral and trans-
cutaneous formulations do not contain PM2.5.
Further, nicotine replacement therapy has been
compared to tobacco cigarettes only for short dura-
tions; but in these short-term comparisons, it does
not increase cardiac risk, even in patients with
known coronary artery disease (65). Nonetheless,
nicotine increases SNA, which should raise concern
over long-term e-cigarette use, especially in young
people who are nonsmokers.
In summary, the absence of combustion and
organic substrates, and the knowledge that
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reassuring. However, the lack of e-liquid regula-
tion, the presence of nicotine as well as detectable
levels of toxicants and metal “impurities” (poten-
tially from the device itself [66]), and the virtually
complete overlap in PM2.5 size and concentration
with tobacco smoke, coupled with reports that
even low exposures to PM2.5 confer signiﬁcant
cardiac risk, are concerning and warrant further
investigation into the physiological effects of these
exposures.
Waterpipes (hookahs). Although waterpipe tobacco
smoking has existed for centuries, its resurgence,
especially among young people, is high; approxi-
mately one in ﬁve of all American college students
admits to waterpipe smoking in the past year (67).
This increase has been attributed to the social
acceptance of waterpipe smoking, social bonding
while sharing a waterpipe, and the misperception
that waterpipe smoking is safe. The cardiac risks of
waterpipe smoking have not been systematically
studied but are likely to be signiﬁcant.
Compared with tobacco cigarette smoking, water-
pipe tobacco smoking has been associated with
greater smoke exposure and increased nicotine and
carbon monoxide blood levels. The effects of water-
pipe tobacco smoking on the autonomic nervous
system can be assumed to be virtually the same as
those with cigarette smoking, and emerging evidence
supports this assumption (68,69). Acute waterpipe
tobacco smoking markedly impairs baroreﬂex control
of the heart rate in otherwise healthy chronic water-
pipe users (70). Not surprisingly, HRV is acutely
decreased during waterpipe tobacco smoking (71).
Importantly, HRV is also decreased when a water-
pipe is used to smoke a nontobacco, non-nicotine,
product, supporting the concept that the PM2.5 and
gaseous components of smoking, not just the nico-
tine, interact adversely with the autonomic nervous
system (71).
In summary, the long-term cardiovascular conse-
quences of waterpipe tobacco smoking in the United
States have not been studied, largely because usage
has only recently increased. However, given the
similarities between waterpipe tobacco smoke and
cigarette tobacco smoke, and the available studies
reporting increased SNA and attenuated baroreﬂex
control, the potential cardiovascular risks are cause
for concern.
Ai r pol lut ion . As noted earlier, the constituents
and size of PM2.5 in air pollution (27) are remarkably
similar to those in cigarette smoke, although at
differing concentrations. The concentration of PM2.5
in mainstream smoke is several-fold greater, butconcentrations in secondhand smoke are on par
with those in air pollution, and of course, exposure
to even low levels of PM2.5 has been associated with
a signiﬁcantly increased cardiac risk (27). In fact,
exposure to PM2.5 in air pollution is recognized to
increase cardiovascular risk and mortality worldwide,
underlying almost 1 million premature deaths per
year (28). Short-term (days to weeks) exposure
to PM2.5 can trigger fatal and nonfatal myocardial
infarction, and long-term (years) exposure increases
cardiovascular mortality (reviewed by Brook et al.
[28]).
Evidence supports the concept that adverse af-
fects on the autonomic nervous system contribute to
this increased cardiac risk (28,29,42,47). As reviewed
earlier, in animal models, exposure to PM2.5 from
diesel exhaust increased efferent cardiac SNA
through the generation of reactive oxygen species
and the activation of TRPV1 receptors present on
vagal afferent C-ﬁbers in the lungs (29,42). In a
meta-analysis of data from 20 studies that included
over 18,000 people, particulate air pollution was
associated with a signiﬁcant reduction in HRV,
consistent with a sympathetic predominance (72).
Unfortunately, direct microneurographic recordings
of SNA and measurements of baroreﬂex function in
humans exposed to air pollution have not been
performed to date and are needed to further eluci-
date mechanisms.
In summary, air pollution increases short-term
and long-term cardiac risk, likely through the acti-
vation of lung afferent C-ﬁbers and subsequent
reﬂex stimulation of efferent cardiac SNA; air pollu-
tion and cigarette smoke (except for the nicotine)
share considerable mechanistic overlap.
CLINICAL IMPLICATIONS
Understanding the mechanisms leading to the sym-
pathetic predominance that accompanies exposures
to nicotine and PM2.5 will lead to therapies to counter
adverse cardiac sequelae. Beta-adrenergic blockers
are already widely used to decrease cardiac risk in
patients with known cardiac disease, but whether
they should be used (and at what threshold) in
habitual smokers without known cardiac disease is
unknown. Similarly, antioxidant therapy, although
disappointing in many established cardiac pop-
ulations, may be more effective in smokers without
established cardiac disease but who had oxidative
stress increase (73). Finally, the development of ag-
onists to CB1 receptors and antagonists to TRPV1 and
TRPA1 receptors may prove a novel therapeutic
strategy (74).
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Acute and long-term exposure to cigarette smoke, in
either active or passive smokers, leads to acute and
chronic changes in the balance of the autonomic
nervous system, resulting in sympathetic predomi-
nance. Acute sympathetic activation during cigarette
smoke exposure has been attributed to nicotine in-
teractions with the autonomic nervous system, with a
contribution by PM2.5. Chronic, sustained effects are
likely principally mediated by lung afferent C-ﬁbers,
either directly through TRPV1 receptors and/or by
generation of oxidative stress. Nicotine uncoupling
of neuronal nitric oxide synthesis in the central
nervous system, either acutely or long-term, has notbeen investigated in humans but may also contri-
bute to sympathetic activation. The baroreﬂex, which
suppresses sympathetic activation, is attenuated
in habitual smokers and plays a permissive role in this
sustained sympathetic activation. Noncigarette
emissions (e.g., marijuana, e-cigarettes, waterpipes,
and air pollution) also interact with the autonomic
nervous system but are understudied.
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